Haisco Pharmaceutical Group Co., Ltd.

This study tests a new inhaled powder called HSK39004 in 376 adults with COPD, a long-term lung disease that makes breathing hard. Participants will use the powder daily for 12 weeks to see if it improves lung function compared to a placebo. The goal is to control symptoms and he…

This study tests an experimental drug called HSK39004, given as an inhaler, in 50 adults with chronic obstructive pulmonary disease (COPD). Participants are randomly assigned to receive either the drug or a placebo for 4 weeks. The main goal is to see if the drug improves lung fu…

This study tests the safety of a drug called HSK31858 in 669 adults with non-cystic fibrosis bronchiectasis, a lung condition that causes repeated infections and breathing problems. Participants who completed a prior study of the same drug will receive the medication and be monit…

This study tests a new tablet called HSK39297 for people with IgA nephropathy, a kidney disease that can lead to kidney failure. The trial includes 73 adults who have already taken the drug in a previous study. They will take the tablet once daily for an extended period, with a p…

This study tests an experimental tablet called HSK39297 in 370 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug can reduce protein in the urine and slow down kidney function decline over 36 to 48 weeks. Participants will be randomly assigned to receiv…

This early-stage trial is testing an experimental oral drug called HSK42360-Na in 159 adults with advanced solid tumors that have a specific genetic change (BRAF V600 mutation). The main goals are to find a safe dose and check for side effects. Researchers will also watch for any…

This study tests an experimental drug called HSK47388 in 150 adults with moderately to severely active ulcerative colitis, a chronic bowel disease causing inflammation and sores. Participants will receive either the drug or a placebo to see if it improves symptoms and helps heal …

This study tests an experimental pill called HSK39297 for people with lupus nephritis, a kidney complication of lupus. About 105 adults will receive either 200 mg, 300 mg, or a placebo daily for several weeks. The main goal is to see if the drug reduces protein in the urine, a si…

This early-stage trial tests an experimental oral drug, HSK47977, in 110 adults with relapsed or refractory Non-Hodgkin's lymphoma. The study has two parts: first, finding the safest dose, then expanding to see how well it works. Participants must have measurable tumors and adequ…

This early-stage trial tests an oral drug called HSK42360 in children aged 6 to 17 with recurrent malignant brain tumors that have a specific BRAF V600 mutation. The study aims to find the safest dose and check for side effects, while also looking at whether the drug can shrink t…

This study tests a new drug called HSK55718 for pain after abdominal surgery. About 200 adults will receive either the new drug, morphine, or a placebo. Researchers will measure pain relief and satisfaction. The goal is to see if HSK55718 is safe and effective.

This study tests a new drug called HSK21542 for pain after hip replacement surgery. About 405 adults will receive either HSK21542, morphine, or a placebo. The goal is to see if HSK21542 reduces pain better and causes fewer side effects like nausea and vomiting.

This early-phase trial tests the safety and tolerability of a new drug called HSK56630 in 40 healthy adults. Participants receive a single dose of the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. No therapeutic benefit is ex…

This Phase 1 study tests the safety and tolerability of a new drug called HSK55879 in 46 healthy adults aged 18 to 45. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. The goal is to gather early safe…

This early-stage study is testing a single dose of the drug HSK39297 in 24 adults with paroxysmal nocturnal hemoglobinuria (PNH) who have mild or moderate liver impairment, compared to those with normal liver function. The goal is to see how the liver affects drug levels and safe…